Drug Development for TB

An expert scientist affiliated with the Center for Discovery and Innovation and a colleague from Harvard T.H. Chan School of Public Health discussed the challenges and priorities in the anti-tuberculosis treatment strategies and drug development. The study published in Nature Reviews Microbiology this week suggests that the preclinical and clinical anti-tuberculosis treatment methodologies depicted in…